Stemrad
Tel Aviv
About Stemrad
Stemrad develops personal protective equipment (PPE) for protection against the effects of acute radiation syndrome and sickness. The company offers 360 Gamma, a wearable PPE that has been developed to protect first-responders and affected populations from the effects of exposure to high doses of gamma radiation. Its PPE is used by nuclear energy operators and safety forces. Stemrad was founded in 2011 and is based in Tel Aviv, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $6.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2017)
- Website: stemrad.com
- Phone: 650-388-9112
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/stemrad-163611 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.